Po-652-06 a novel measure to identify inequity in the treatment of atrial fibrillation: decreased access to cardioversion/ablation in counties with low health rankings

Adequate treatment of atrial fibrillation (AF) is critical for managing patient stroke risk and quality of life. Cardioversion and ablation (CV/A) procedures are commonly performed to treat AF, yet differences in access to these treatments have not been explored from a population health perspective.